Rymedi Reaches Major Milestone with First Patent Grant

SOUTH CAROLINA – October 3, 2024 – Rymedi, a frontrunner in blockchain-based healthcare data management, is excited to announce the issuance of its first patent. This achievement marks a key advancement in Rymedi’s mission to improve human health through secure, transparent, and efficient data solutions.

Rymedi’s platform empowers life science organizations—including clinical trials, medical labs, diagnostic testing companies, medical device firms, and toxicology labs—to enhance patient engagement and effectively manage both individual and population health data. This newly patented technology reinforces Rymedi’s dedication to transforming healthcare by providing innovative ways to manage critical health information.

“This patent reflects our commitment to pushing the boundaries of healthcare data management,” said David Stefanich, CEO of Rymedi. “We’re focused on providing advanced tools that help organizations securely manage and leverage health data, driving meaningful improvements in the healthcare landscape.”

Rymedi’s secure and transparent platform is a cornerstone for improving human health, addressing vital needs within the healthcare industry. Through our platform we continue to support organizations to improve human health through wellness, clinical trials, diagnostic testing, and protecting patient data.

For more information about Rymedi’s patented technology, please contact us at sales@rymedi.com.

About Rymedi

Rymedi is a leader in healthcare data management, utilizing blockchain technology to enhance patient engagement and ensure data security. The company’s mission is to drive innovation in healthcare by offering cutting-edge solutions for efficient, transparent data management. For more information, visit www.rymedi.com or contact us at sales@rymedi.com.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.